All Pharmaceutical Microbiology articles – Page 4
-
NewsNew guideline for Helicobacter pylori includes change to primary treatment recommendation
New guidelines on the treatment of Helicobacter pylori (H. pylori) infection warn against prescribing PPI triple therapy, instead advising practitioners to use bismuth quadruple therapy or one of the other suggested treatment options.
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsScientists seek more effective treatment for under-the-radar STI
Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted infection (STI) worldwide, continues to fly under the radar.
-
NewsNew microbial fermentation manufacturing facility launched in Billingham
The UK’s life science sector has been bolstered by a £100m investment by FUJIFILM Diosynth Biotechnologies. This takes the form of a new microbial fermentation manufacturing facility in Billingham.
-
NewsDairy farmer study reveals need for greater One Health understanding in AMR management
A new study has found a need for greater engagement and collaboration between veterinarians, farmers and regulators to improve understanding and management of antimicrobial resistance and One Health amongst Aotearoa New Zealand farmers.
-
NewsNanoparticle platform offers step toward more effective Covid and HIV vaccines
Researchers have developed a nanoparticle platform that could make existing vaccines more effective, including those for influenza, COVID-19, and HIV.
-
NewsResearchers find promising new weapon against certain types of antibiotic-resistant bacteria
Researchers have discovered a new combination of substances that appears to combat a range of bacteria that causes conditions such as stomach ulcers and urinary tract infections, and that are increasingly developing antibiotic resistance.
-
NewsNew study looks at drug exposures of COVID-19 therapy for pregnant women
A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the SARS-CoV-2 coronavirus in pregnant women.
-
News3D bioprinting advances research on respiratory viruses
A research team has successfully created artificial lungs, designed to study infections and test drugs for respiratory diseases including COVID-19.
-
NewsBreakthrough in the synthesis of fungal bioactive compounds for therapeutic applications
Researchers have developed an efficient method to synthesize eutyscoparol A and violaceoid C, two promising bioactive compounds that are produced by fungi.
-
NewsDengue vaccine is effective and safe, reveals first global meta-analysis
The study, conducted by cross-referencing data from 19 scientific studies, involving over 20,000 individuals, shows an efficacy rate of over 50% in reducing disease cases, with lasting effects and a high safety profile.
-
NewsMulti-omics strategy reveals how insect parasite fungus ameliorates sepsis-associated acute kidney injury
Scientists have found that Cordyceps sinensis significantly ameliorates renal injury and inflammation in sepsis-associated acute kidney injury (S-AKI) by regulating mitochondrial energy metabolism and macrophage polarization.
-
NewsResearchers create new treatment and vaccine for flu and various coronaviruses
A team of researchers has discovered two new ways of preventing and treating respiratory viruses using nasal sprays.
-
NewsResearchers engineer ‘cat parasite’ Toxoplasma gondii to release therapeutic proteins in the human brain
In a breakthrough study by an international team of scientists, the ‘cat parasite’ Toxoplasma gondii was engineered to deliver drugs to the human brain.
-
NewsNew study highlights scale and impact of long COVID
A wide range of biological mechanisms are involved in long Covid, including persistence of the original virus in the body, disruption of the normal immune response, and microscopic blood clotting, even in some people who had only mild initial infections.
-
NewsSuper cally molecules take down tuberculosis
Researchers have identified and synthesised a group of molecules that can act against the cause of tuberculosis in a new way. The callyaerins act against TB by employing a fundamentally different mechanism compared to antibiotic agents used to date.
-
News‘Russian doll’ packaging could boost drug delivery
Researchers have developed a new technology that lets them create compartments within compartments on the nanoscale, which can mean timing drug release for maximum effect at the site where it’s most needed.
-
NewsChinese medicinal fungus shows promise in treating idiopathic pulmonary fibrosis
A recent study from China has reported that Cordyceps sinensis (CS), a traditional Chinese medicinal fungus, can ameliorate idiopathic pulmonary fibrosis (IPF) in mice by inhibiting mitochondrion-mediated oxidative stress.
-
NewsExploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international clinical trial primarily funded by the National Institutes of Health (NIH). There ...
-
NewsDual action antibiotic could make bacterial resistance nearly impossible
A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research
